Therefore, even if the prevalence of this type of liver cancer is very low, sHCC‐ICC should be suspected in patients with a simultaneous increase in serum levels of AFP and CA19‐9 [10]. The gene discussed is AFP; the disease is intrahepatic cholangiocarcinoma.